Stroke thrombolysis: leaving the past, understanding the present and moving forward …

Comment

Christopher Bladin et al. Emerg Med Australas. 2013 Apr.

. 2013 Apr;25(2):195-6.

doi: 10.1111/1742-6723.12025.

No abstract available

Comment in

Response from Prof. Fatovich to Stroke thrombolysis: Leaving the past, understanding the present and moving forward ….
Fatovich DM. Fatovich DM. Emerg Med Australas. 2013 Apr;25(2):196-7. doi: 10.1111/1742-6723.12055. Emerg Med Australas. 2013. PMID: 23560974 No abstract available.
Response from Drs Hoffman and Cooper to Stroke thrombolysis: Leaving the past, understanding the present and moving forward ….
Hoffman JR, Cooper RJ. Hoffman JR, et al. Emerg Med Australas. 2013 Apr;25(2):197-8. doi: 10.1111/1742-6723.12056. Emerg Med Australas. 2013. PMID: 23560975 No abstract available.

How is more negative evidence being used to support claims of benefit: The curious case of the third international stroke trial (IST-3).
Hoffman JR, Cooper RJ. Hoffman JR, et al. Emerg Med Australas. 2012 Oct;24(5):473-6. doi: 10.1111/j.1742-6723.2012.01604.x. Emerg Med Australas. 2012. PMID: 23039286 No abstract available.
Believing is seeing: stroke thrombolysis remains unproven after the third International Stroke Trial (IST-3).
Fatovich DM. Fatovich DM. Emerg Med Australas. 2012 Oct;24(5):477-9. doi: 10.1111/j.1742-6723.2012.01605.x. Emerg Med Australas. 2012. PMID: 23039287 No abstract available.